No Data
Should You Buy Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) For Its Upcoming Dividend?
The Returns At Huaxia Eye Hospital GroupLtd (SZSE:301267) Aren't Growing
Huaxia Eye (301267.SZ): Cumulative expenditure of 176 million yuan to repurchase 6.3124 million shares.
On July 1st, Gelonghui reported that Huaxia Ophthalmology (301267.SZ) has cumulatively repurchased 6,312,440 shares of the company through a share repurchase special account for centralized auction trading method as of June 30th, 2024, accounting for 0.75% of the company's current total share capital. The highest fill price was 30.93 yuan/share, the lowest fill price was 20.69 yuan/share, and the total fill amount was 175,978,500 yuan (excluding transaction costs).
Express News | Huaxia Eye Hospital Says Actual Controller, Chairman SU Qingcan Released From Detention and Placed Under Residential Surveillance
Huaxia Eye Hospital (301267.SZ) has repurchased 0.62% of the shares.
Huaxia Eye Medicine(301267.SZ) announced that by May 31, 2024, it repurchased a total of 5,225,140 shares through the share repurchase securities account in the concentrated bidding trading method, accounting for 0.62% of the company's current total share capital. The highest fill price was 30.93 yuan/share, and the lowest fill price was 25.01 yuan/share. The total accumulated transaction amount was 150,985,900 yuan (excluding transaction fees).
Huaxia Eye Hospital GroupLtd (SZSE:301267) Has A Rock Solid Balance Sheet
Returns On Capital At Huaxia Eye Hospital GroupLtd (SZSE:301267) Have Hit The BrakesNo Data
